SENNA-S- sennosides 8.6 mg and docusate sodium 50 mg tablet

Senna-S by

Drug Labeling and Warnings

Senna-S by is a Otc medication manufactured, distributed, or labeled by NUVICARE LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active Ingredients (in each tablet)

Docusate Sodium 50 mg

Sennosides 8.6 mg

Purpose

Docusate Sodium............... Stool softener

Sennosides........................Laxative

Uses:

• Relieves occasional constipation (irregularity).
• Generally produces a bowel movement in 6 to 12 hours.

Warnings:

Do not use: If you are now taking mineral oil, unless directed by a doctor. Laxative products for longer than 1 week, unless directed by a doctor.

ASK DOCTOR

Ask a doctor before use if you have: 

• Stomach pain
• nausea
• vomiting
• Noticed a sudden change in bowel habits that continues over a period of 2 weeks.

STOP USE

Stop use and ask a doctor if you have:

• Rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

PREGNANCY OR BREAST FEEDING

• If pregnant or breast-feeding, ask a health professional before use.

KEEP OUT OF REACH OF CHILDREN

KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

DIRECTIONS

Take preferably at bedtime or as directed by a doctor.

age	starting dosage	maximum dosage
adults & children 12 years of age and over	2 tablets once a day	4 tablets twice a day
children 6 to under 12 years	1 tablet once a day	2 tablets twice a day
children 2 to under 6 years	1 /2 tablet once a day	1 tablet twice a day
children under 2 years	ask a doctor	ask a doctor

OTHER INFORMATION

• Each tablet contains: Calcium 19.92 mg, Sodium 5.61 mg VERY LOW SODIUM
• store at 25°C (77°F) excursions permitted between15°-30°C (59°-86°F)

INACTIVE INGREDIENTS

Croscarmellose Sodium, Colloidal Silicon Dioxide, Dicalcium Phosphate, F D & C Red, Hypromellose, Magnesium Stearate, Microcrystalline Cellulose, Maltodextrin, Polyethylene Glycol, Stearic acid Powder, Titanium Dioxide.

QUESTIONS OR COMMENTS?

Call 1 (718) 337-8733 or visit: support@nuvicare.com

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

SENNA-S 
sennosides 8.6 mg and docusate sodium 50 mg tablet

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 84324-013
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG)	DOCUSATE SODIUM	50 mg
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX)	SENNOSIDES	8.6 mg

Inactive Ingredients
Ingredient Name	Strength
Croscarmellose Sodium (UNII: M28OL1HH48)
Silicon Dioxide (UNII: ETJ7Z6XBU4)
ANHYDROUS DIBASIC CALCIUM PHOSPHATE (UNII: L11K75P92J)
FD&C RED NO. 3 (UNII: PN2ZH5LOQY)
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
Magnesium Stearate (UNII: 70097M6I30)
Microcrystalline Cellulose (UNII: OP1R32D61U)
Maltodextrin (UNII: 7CVR7L4A2D)
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
STEARIC ACID (UNII: 4ELV7Z65AP)
Titanium Dioxide (UNII: 15FIX9V2JP)

Product Characteristics
Color	red	Score	no score
Shape	ROUND	Size	10mm
Flavor		Imprint Code	none
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 84324-013-01	100 in 1 BOTTLE; Type 0: Not a Combination Product	07/17/2024

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	505G(a)(3)	07/17/2024

Labeler - NUVICARE LLC (119257565)

Registrant - NUVICARE LLC (119257565)